Who's Eligible Anyway? Risk Modeling for Clinical Trial Accrual.
Accrual continues to be a challenge for oncology clinical trials. Interventions to enhance accrual after study activation exist, including corrective action plans for NCI-sponsored trials. Clinical trials would benefit from a proactive approach rather than a reactive approach. Accrual strategy planning early in trial development is suggested. Clin Cancer Res; 22(22); 5397-9. ©2016 AACRSee related article by Massett et al., p. 5408.
Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.
Kathryn F
KF
Mileham
Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina. Edward.Kim@carolinashealthcare.org.
Edward S
ES
Kim
D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D008495:Medical Oncology / Q000379:methods*; D054547:National Cancer Institute (U.S.); D018579:Patient Selection; D012107:Research Design; D012306:Risk; D014481:United States